ABEO vs TECH · rev $3.5M vs P/E 65, rev $1.22B
Abeona Therapeutics Inc (ABEO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ABEO currently screens at market cap $301.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ABEO and TECH stock pages for the full models.
Not investment advice.